GlassScriptPhysician profile
Sheila Johnson
NPI 1023061231
$687.48
in general payments reported to CMS, 2019-2025
12 companies · $77.94 in 2025
The $77.94 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $208 · 2023: $204 · 2024: $16.70 · 2025: $77.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $234.41 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $128.65 | 2021 | |
| Amneal Pharmaceuticals LLC | $71.56 | 2023 | Lyvispah |
| Gilead Sciences, INC. | $60.87 | 2025 | |
| Scilex Pharmaceuticals INC. | $39.03 | 2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.57 | 2023-2024 | Relistor |
| Lilly USA, LLC | $31.28 | 2023 | Mounjaro |
| Scynexis, INC. | $25.87 | 2022 | |
| Organon LLC | $17.07 | 2025 | Nexplanon |
| Azurity Pharmaceuticals, INC. | $15.09 | 2023 | Horizant |
| Astrazeneca Pharmaceuticals LP | $13.24 | 2023 | Farxiga |
| Glaxosmithkline, LLC. | $12.84 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.